formally known as gpha

Same medicine. Same results.
Lower cost.

Other Resources

For Consumers

Below are additional resources for consumers seeking more information about their medicines, health care services, or other programs.

Centers for Medicare and Medicaid Services (CMS)

Medicare Prescription Drug Coverage Information (CMS)

Frequently Asked Questions About Generic Drugs, FDA web site

FDA and Bioequivalence: FDA's information helps consumers understand that generic medicines must have the same active ingredients and produce the same results in order to receive approval.

National Council on Patient Information and Education (NCPIE): NCPIE is a consumer group that works to advance the safe, appropriate use of medicines through enhanced communication. GPhA is a member.

MedWatch: The FDA's safety information and adverse event reporting program.


For Researchers

Patent Expirations

Drugs@FDA: FDA's searchable database of approved medicines. Use this database if you are searching for available generics.

FDA Electronic Orange Book: The FDA's official book of approved drugs, which includes patent dates.

Generic Sales and Prescriptions

Pharmacy Facts and Figures, Drug Topics Magazine: Lists the top brand and generic medicines by retail sales and prescriptions dispensed.

RxList: An online medical resource dedicated to offering detailed and current pharmaceutical information on brand and generic drugs.

The Generic Approvals

FDA Generic Drug Guidances: Frequently asked questions and guide to submitting an ANDA or NDA.

Other Resources

U.S. Pharmacopeia (USP): USP is a scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements manufactured, distributed and consumed worldwide. USP’s drug standards are enforceable in the United States by the Food and Drug Administration, and these standards are developed and relied upon in more than 140 countries.

European Generic Medicines Association: The official representative body of the European generic and biosimilar pharmaceutical industry at the forefront of providing high-quality affordable medicines to millions of Europeans and stimulating competitiveness and innovation in the pharmaceutical sector.

Canadian Generic Pharmaceutical Association: Represents the Canadian-based generic pharmaceutical industry: a dynamic group of companies which specialize in the production of high quality, affordable generic drugs, fine chemicals and new chemical entities.

International Generic Pharmaceutical Alliance: Represents the global generic industry to ensure that all consumers have access to affordable quality medicines. IGPA is the official representative body of the generic industry in relations with the ICH, WHO and other international organizations. The International Generic Pharmaceutical Alliance was founded in March 1997 and consists of the EGA (Europe), CGPA (Canada), GPhA (USA), IPA (India) and JGA (Japan). The IGPA has also granted observer status to the generic medicines association of Brazil, Jordan, Taiwan and South Africa.

** GPhA is not responsible for the content of outside web sites.